Pradeep Natarajan: Can Polygenic Risk Scores Refine Risk Stratification in Secondary Prevention of CAD
Pradeep Natarajan, Director, Preventive Cardiology at Massachusetts General Hospital, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in American Journal of Preventive Cardiology:
“Guidelines recommend risk stratification for secondary prevention to support more aggressive LDL-C-lowering.
Our study by Jennifer Halford and with Akl Fahed shows how coronary artery disease polygenic risk scoring can further improve risk stratification in secondary prevention.”
Title: Genetic and clinical risk factors for recurrent events among patients with coronary artery disease
Authors: Jennifer L Halford, Satoshi Koyama, Yang Sui, So Mi Jemma Cho, Tiffany R Bellomo, Anika Misra, Aniruddh P Patel, Whitney Hornsby, Akl C Fahed, Pradeep Natarajan
Other posts featuring Pradeep Natarajan on Hemostasis Today.
-
Jul 23, 2026, 15:58Mel Snyder: Beyond Sickle Cell Disease to the Future of Pediatric Genetics
-
Jul 23, 2026, 15:43Lorna Knight: The Next Frontier in Sickle Cell Disease Is Access
-
Jul 23, 2026, 15:29Ben Kleinstiver: Overcoming a Major Barrier to Scalable Gene Editing
-
Jul 23, 2026, 15:28Modernizing DIC Diagnosis in Cirrhosis: Building an International Registry for Precision Hemostasi
-
Jul 23, 2026, 14:32Saneha Anjum Shaikh: Why Antibody Screening Must Be Standard Practice in Modern Blood Banking
-
Jul 23, 2026, 14:00Ron Vezina: Canadian Blood Services Issues Urgent Donation Appeal
-
Jul 23, 2026, 13:46Sebastian Szmit: Understanding Troponins in Modern Cardio-Oncology
-
Jul 23, 2026, 13:41Colleen Grady: Why Normal Hemoglobin Does Not Exclude Iron Deficiency
-
Jul 23, 2026, 13:22Jacob Kelly: AHA Review Highlights Coffee’s Cardiovascular Benefits